These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 14550424)

  • 1. Indications for early cystectomy.
    Stein JP
    Urology; 2003 Oct; 62(4):591-5. PubMed ID: 14550424
    [No Abstract]   [Full Text] [Related]  

  • 2. T1G3 bladder cancer--the case for TUR and BCG.
    Miller K
    Front Radiat Ther Oncol; 2002; 36():147-50. PubMed ID: 11842744
    [No Abstract]   [Full Text] [Related]  

  • 3. Outcome of patients undergoing radical cystectomy for invasive bladder cancer.
    Gschwend JE
    Front Radiat Ther Oncol; 2002; 36():106-17. PubMed ID: 11842741
    [No Abstract]   [Full Text] [Related]  

  • 4. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 5. Recurrence and progression of stage T1, grade 3 transitional cell carcinoma of the bladder following intravesical immunotherapy with bacillus Calmette-Guerin.
    Brake M; Loertzer H; Horsch R; Keller H
    J Urol; 2000 Jun; 163(6):1697-701. PubMed ID: 10799163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T1G3: What to do?
    Mandressi A
    Arch Ital Urol Androl; 1996 Feb; 68(1):5-7. PubMed ID: 8664922
    [No Abstract]   [Full Text] [Related]  

  • 7. Bladder cancer--resection/ablation.
    Corica FA; Keane TE
    Surg Oncol Clin N Am; 2005 Apr; 14(2):321-52. PubMed ID: 15817242
    [No Abstract]   [Full Text] [Related]  

  • 8. [Radical cystectomy for superficial tumors in the BCG era].
    Huguet Pérez J; Palou J; Millán Rodríguez F; Villavicencio Mavrich H; Rodríguez JV
    Arch Esp Urol; 2002; 55(1):50-6. PubMed ID: 11957752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Invasive T1 bladder cancer: indications and rationale for radical cystectomy.
    Stein JP; Penson DF
    BJU Int; 2008 Aug; 102(3):270-5. PubMed ID: 18494831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update.
    Hall MC; Chang SS; Dalbagni G; Pruthi RS; Seigne JD; Skinner EC; Wolf JS; Schellhammer PF
    J Urol; 2007 Dec; 178(6):2314-30. PubMed ID: 17993339
    [No Abstract]   [Full Text] [Related]  

  • 11. Management of high-risk non-muscle invasive bladder cancer.
    Brausi M; Olaru V
    Minerva Urol Nefrol; 2012 Dec; 64(4):255-60. PubMed ID: 23288212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 and T2 bladder cancer: selecting optimal therapy.
    Soloway MS
    Eur Urol; 1998; 33 Suppl 4():16-7. PubMed ID: 9615202
    [No Abstract]   [Full Text] [Related]  

  • 13. T2a transitional cell carcinoma of the bladder: long-term experience with intravesical immunoprophylaxis with bacillus Calmette-Guerin.
    Volkmer BG; Gschwend JE; Maier SH; Seidl-Schlick EM; Bach D; Romics I
    J Urol; 2003 Mar; 169(3):931-4; discussion 934-5. PubMed ID: 12576815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radical cystectomy in patients with non-muscle invasive bladder cancer who fail BCG therapy].
    Huguet J; Gaya JM; Sabaté S; Palou J; Villavicencio H
    Actas Urol Esp; 2010 Jan; 34(1):63-70. PubMed ID: 20223134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radical cystectomy--often too late? 1987.
    Stockle M; Alken P; Engelmann U; Jacobi GH; Riedmiller H; Hohenfellner R
    Eur Urol; 2006 Dec; 50(6):1132-8. PubMed ID: 17183625
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of high-risk, non-muscle-invasive bladder cancer.
    Lerner SP
    Nat Clin Pract Urol; 2006 Aug; 3(8):398-9. PubMed ID: 16902498
    [No Abstract]   [Full Text] [Related]  

  • 17. A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancer.
    Scher HI
    J Urol; 1994 Aug; 152(2 Pt 1):574-5. PubMed ID: 8015114
    [No Abstract]   [Full Text] [Related]  

  • 18. Current problems and needs in the treatment of pT1 G3 bladder carcinoma.
    Martínez Portillo FJ; Alken P
    Int Urol Nephrol; 2002; 33(1):29-40. PubMed ID: 12090335
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG treatment of superficial transitional cell carcinoma.
    Schellhammer PF
    Urology; 1991; 37(5 Suppl):16-8. PubMed ID: 2021030
    [No Abstract]   [Full Text] [Related]  

  • 20. BCG in bladder cancer--a warning.
    Nicol D
    Aust N Z J Med; 1995 Aug; 25(4):275-7. PubMed ID: 8540864
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.